Oxford Biomedica Stock Price, News & Analysis (OTCMKTS:OXBDF)

$0.11 0.00 (0.00 %)
(As of 01/16/2018 07:38 AM ET)
Previous Close$0.11
Today's RangeN/A
52-Week Range$0.04 - $0.16
VolumeN/A
Average Volume30,319 shs
Market Capitalization$341.85 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Oxford Biomedica (OTCMKTS:OXBDF)

Oxford Biomedica logoOxford BioMedica plc, a biopharmaceutical company, researches, develops, and produces gene and cell therapy products for the treatment of ocular, neurodegenerative, and cancer diseases in Europe and rest of world. The company operates through Partnering and R&D segments. Its LentiVector platform technology integrates genes into non-dividing cells in the brain and the eye, as well as accommodates multiple therapeutic genes. The company’s products under development include OXB-102 that has completed Phase I/II trial for the treatment of Parkinson's disease; OXB-202, which is in a Phase I/IIa trial preparation for the prevention of corneal graft rejection; OXB-301, a cancer vaccine which is in a Phase I/II trial; and OXB-302, which is based on an autologous T-cell that is engineered using a lentiviral vector to express a chimeric antigen receptor targeting multiple cancers, as well as OXB-201 that is in Phase I/II trial for the treatment of ‘wet’ age-related macular degeneration and diabetic retinopathy. It is also developing SAR 422459 that is in a Phase II trial for the treatment of Stargardt disease; and SAR 421869, a gene-based therapy that is in Phase I/II trial for the treatment of Usher syndrome 1B. The company has partnerships with Sanofi, GlaxoSmithKline, Novartis, Green Cross LabCell, and Immune Design Corp. Oxford BioMedica plc was founded in 1995 and is headquartered in Oxford, the United Kingdom.

Receive OXBDF News and Ratings via Email

Sign-up to receive the latest news and ratings for OXBDF and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:OXBDF
CUSIPN/A
Phone44-18-6578-3000

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$37.67 million
Price / Sales9.07
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares3,107,700,000

Oxford Biomedica (OTCMKTS:OXBDF) Frequently Asked Questions

What is Oxford Biomedica's stock symbol?

Oxford Biomedica trades on the OTCMKTS under the ticker symbol "OXBDF."

When will Oxford Biomedica make its next earnings announcement?

Oxford Biomedica is scheduled to release their next quarterly earnings announcement on Wednesday, March, 21st 2018. View Earnings Estimates for Oxford Biomedica.

Who are some of Oxford Biomedica's key competitors?

How do I buy Oxford Biomedica stock?

Shares of Oxford Biomedica can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Oxford Biomedica's stock price today?

One share of Oxford Biomedica stock can currently be purchased for approximately $0.11.

How big of a company is Oxford Biomedica?

Oxford Biomedica has a market capitalization of $341.85 million and generates $37.67 million in revenue each year.

How can I contact Oxford Biomedica?

Oxford Biomedica's mailing address is Windrush Court Transport Way, Oxford X0, OX4 6LT. The company can be reached via phone at 44-18-6578-3000.


MarketBeat Community Rating for Oxford Biomedica (OXBDF)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  9 (Vote Outperform)
Underperform Votes:  11 (Vote Underperform)
Total Votes:  20
MarketBeat's community ratings are surveys of what our community members think about Oxford Biomedica and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Oxford Biomedica (OTCMKTS:OXBDF) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

Oxford Biomedica (OTCMKTS:OXBDF) Consensus Price Target History

Price Target History for Oxford Biomedica (OTCMKTS:OXBDF)

Oxford Biomedica (OTCMKTS:OXBDF) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
10/31/2017HC WainwrightReiterated RatingBuyView Rating Details
12/5/2016Roth CapitalReiterated RatingBuyView Rating Details
(Data available from 1/16/2016 forward)

Earnings

Earnings History for Oxford Biomedica (OTCMKTS:OXBDF)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Oxford Biomedica (OTCMKTS:OXBDF) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.01 EPS

Dividends

Dividend History for Oxford Biomedica (OTCMKTS:OXBDF)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Oxford Biomedica (OTCMKTS OXBDF)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Oxford Biomedica (OTCMKTS OXBDF) News Headlines

Source:
DateHeadline
Oxford BioMedica PLC (LON:OXB): Has Recent Earnings Growth Beaten Long-Term Trend?Oxford BioMedica PLC (LON:OXB): Has Recent Earnings Growth Beaten Long-Term Trend?
finance.yahoo.com - December 20 at 10:14 AM

SEC Filings

Oxford Biomedica (OTCMKTS:OXBDF) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Oxford Biomedica (OTCMKTS OXBDF) Stock Chart for Tuesday, January, 16, 2018

Loading chart…

This page was last updated on 1/16/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.